Approval · Notice of Compliance 30079 · 2023
CAMBIA: Notice of Compliance 30079
Issued February 8, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30079
- Date
- February 8, 2023
- Company
- Aralez Pharmaceuticals Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the inner and outer labels to comply with Plain Language Labelling (PLL) requirements.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMBIA | Not yet assigned | — |
Medicinal ingredients
- DICLOFENAC POTASSIUM 50 MG per SACHET